Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fresh Off BMS Deal, Leading Chinese CRO WuXi PharmaTech Outlines Plan To Expand Biologics Business To Keep Pace With Big Pharma

This article was originally published in PharmAsia News

Executive Summary

BEIJING - Betting on the belief that Big Pharma will speed up the transfer of research and manufacturing to China, leading contract research organization WuXi PharmaTech is expanding its chemistry services even while preparing to launch a new biologics testing and production center near its headquarters in Shanghai
Advertisement

Related Content

Large Chinese CROs To Benefit From Continued Outsourcing Trend, CRO Surveys Say
From Biologics To Corporate Venture, China's Leading CRO Continues To Evolve
WuXi Celebrates First $100 Million Quarter; Sinovac Reports 50% Revenue Increase; SciClone Not Worried About Zydaxin Cuts: China Earnings Round Up (Part 1)
China's Leading CRO WuXi Looks To Utilize Manufacturing Capacity With Telaprevir
The Rise Of The Chinese CRO: New Models For An Emerging Player
Japanese Nuclear Crisis Triggers Panic Buying Of Food And Drugs In China, Along With Selling Of Chinese Life Science Stocks
Chinese CRO ShangPharma Moving Into Biologics, Small-scale Manufacturing To Broaden Customer Pool
Charles River Abandons WuXi PharmaTech Just Days Before Crucial Shareholder Votes On Planned Merger
Charles River Abandons WuXi PharmaTech Just Days Before Crucial Shareholder Votes On Planned Merger
WuXi PharmaTech Founder Ge Li Says Upcoming Merger With Charles River Is Part Of Globalization Of The Drive To Save Lives
Advertisement
UsernamePublicRestriction

Register

SC077351

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel